Results 171 to 180 of about 2,285,787 (260)

m6A-Modified Nucleotide Bases Improve Translation of In Vitro-Transcribed Chimeric Antigen Receptor (CAR) mRNA in T Cells. [PDF]

Int J Mol Sci
Lao N, Li S, Ainciburu M, Barron N.
europepmc   +1 more source

The Price of Remission: Modeling the Total Financial Burden, Quality-of-Life Impairment, and Healthcare Dependence in Lupus Compared With Chimeric Antigen Receptor (CAR) T-cell Therapy. [PDF]

Cureus
Kumar K, Kim K.
europepmc   +1 more source

Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions. [PDF]

J Immunother Cancer
Walton CM, Bell M, O'Neil R, Sahin O, Choi BD, Fecci PE, Strickland BA.   +6 more
europepmc   +1 more source

Elucidating HER2-directed chimeric antigen receptor (CAR) activation mechanism using homology modeling and all-atom molecular dynamics simulation. [PDF]

Comput Struct Biotechnol J
Hryb M, Davis L, Lao S, Paradis NJ, Staehle M, Mou X, Wu C.   +6 more
europepmc   +1 more source

Sex Differences in Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy. [PDF]

Cancer Med
Tan JY, Yeo YH, Kin HWK, Ang QX, Chisti MM, Ezekwudo D, Hilal T.   +6 more
europepmc   +1 more source

A universal chimeric antigen receptor (CAR)-fragment antibody binder (FAB) split system for cancer immunotherapy. [PDF]

Sci Adv
Arina A, Arauz E, Masoumi E, Warzecha KW, Sääf A, Widło Ł, Slezak T, Zieminska A, Dudek K, Schaefer ZP, Lecka M, Usatyuk S, Weichselbaum RR, Kossiakoff AA.   +13 more
europepmc   +1 more source

Predictors of Neurotoxicity in a Large Cohort of Italian Patients Undergoing Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy. [PDF]

Brain Behav
Modoni A, Vollono C, Galli E, Capriati L, Sorà F, Hohaus S, Servidei S, Piccirillo N, Calabresi P, Sica S.   +9 more
europepmc   +1 more source

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. [PDF]

Nat Commun
Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY, Solit DB, Rosenberg JE, Al-Ahmadie H, Ding CCK, Chan E, Steri V, Porten SP, Koshkin VS, Friedlander TW, Feng FY, Lee JK, Wiita AP, Chu CE, Chou J.   +25 more
europepmc   +1 more source

CD4-Based Chimeric Antigen Receptor (CAR)-T Cells With Resistance to HIV-1 Infection and Enhanced Anti-HIV Efficacy: Covalent Interaction Between CD4-CAR and HIV-1 Envelope Glycoprotein. [PDF]

J Med Virol
Lou Y, He X, Li G, Sikhondze M, Ma J, Du H, Ouyang X, Dotti G, Sajadi M, Su L.   +9 more
europepmc   +1 more source

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma. [PDF]

Neuro Oncol
Wu BX, Kreatsoulas D, Cam H, Bolyard C, Chang Y, Mandula J, Welsh PW, Wang Z, Li A, Weltge P, Reynolds K, Amankwah Y, Elder JB, Giglio P, Otero JJ, Rajappa P, Gerald D, Chung D, Ma Q, Velegraki M, Li Z.   +20 more
europepmc   +1 more source